Last updated: 16 May 2024 at 4:56pm EST

Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. Net Worth




The estimated Net Worth of Mark William Lowdell is at least 10 百万$ dollars as of 3 November 2021. Dr Lowdell owns over 701 units of INmune Bio stock worth over 9,175,500$ and over the last 5 years he sold INMB stock worth over 673,960$. In addition, he makes 149,478$ as Chief Scientific Officer & Chief Manufacturing Officer at INmune Bio.

Dr D INMB stock SEC Form 4 insiders trading

Dr has made over 5 trades of the INmune Bio stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 701 units of INMB stock worth 14,020$ on 3 November 2021.

The largest trade he's ever made was selling 30,000 units of INmune Bio stock on 7 July 2021 worth over 604,800$. On average, Dr trades about 4,042 units every 87 days since 2019. As of 3 November 2021 he still owns at least 1,472,793 units of INmune Bio stock.

You can see the complete history of Dr Lowdell stock trades at the bottom of the page.





Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. biography

Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. is the Chief Scientific Officer & Chief Manufacturing Officer at INmune Bio.

What is the salary of Dr D?

As the Chief Scientific Officer & Chief Manufacturing Officer of INmune Bio, the total compensation of Dr D at INmune Bio is 149,478$. There are 3 executives at INmune Bio getting paid more, with Dr. Raymond Joseph Tesi M.D. having the highest compensation of 455,000$.



How old is Dr D?

Dr D is 58, he's been the Chief Scientific Officer & Chief Manufacturing Officer of INmune Bio since . There are 2 older and 1 younger executives at INmune Bio. The oldest executive at INmune Bio, Inc. is Dr. Raymond Joseph Tesi, 65, who is the Co-Founder, Pres, CEO, Chief Medical Officer & Chairman.

What's Dr D's mailing address?

Mark's mailing address filed with the SEC is C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON,, FL, 33432.

Insiders trading at INmune Bio

Over the last 5 years, insiders at INmune Bio have traded over 5,236,202$ worth of INmune Bio stock and bought 82,618 units worth 534,813$ . The most active insiders traders include Linda F PowersEdgardo Jr BaracchiniInc Xencor. On average, INmune Bio executives and independent directors trade stock every 51 days with the average trade being worth of 117,087$. The most recent stock trade was executed by Scott Juda on 25 June 2024, trading 5,000 units of INMB stock currently worth 36,350$.



What does INmune Bio do?

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.



What does INmune Bio's logo look like?

INmune Bio, Inc. logo

Complete history of Dr Lowdell stock trades at INmune Bio

日付
#
会社
インサイダー
取引
取引
株式 1株当たりの株価 合計金額 その後の株式数 ソース
3 Nov 2021 Mark William Lowdell
Chief Scientific Officer
販売 701 20.00$ 14,020$
3 Nov 2021
1,472,793
27 Oct 2021 Mark William Lowdell
Chief Scientific Officer
販売 2,357 20.00$ 47,140$
27 Oct 2021
1,473,494
22 Oct 2021 Mark William Lowdell
Chief Scientific Officer
販売 400 20.00$ 8,000$
22 Oct 2021
1,475,851
7 Jul 2021 Mark William Lowdell
Chief Scientific Officer
販売 30,000 20.16$ 604,800$
7 Jul 2021
1,476,251
11 Sep 2019 Mark William Lowdell
Chief Scientific Officer
購入する 2,918 6.23$ 18,179$
11 Sep 2019
1,506,251


INmune Bio executives and stock owners

INmune Bio executives and other stock owners filed with the SEC include: